The overexpression of VEGF has been implicated in the proliferation of neuroendocrine tumor cells, among other malignancies [19], leading to the increasing utilization of agents targeted against the VEGF pathway. This evidence concerns the gene VEGFA and neuroendocrine neoplasm.